Strategies for Use of a Limited Influenza Vaccine Supply

This publication has 12 references indexed in Scilit:

• Serum Antibody Responses after Intradermal Vaccination against Influenza
  New England Journal of Medicine, 2004
• Dose Sparing with Intradermal Injection of Influenza Vaccine
  New England Journal of Medicine, 2004
• Safety, Efficacy, and Effectiveness of Live, Attenuated, Cold‐Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years
  Clinical Infectious Diseases, 2004
• Disruption of Services in an Internal Medicine Unit Due to a Nosocomial Influenza Outbreak
  Infection Control & Hospital Epidemiology, 2002
• Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults
  Vaccine, 2002
• Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children
  The Pediatric Infectious Disease Journal, 2001
• Comparison of the Safety, Vaccine Virus Shedding, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold‐Adapted, Administered to Human Immunodeficiency Virus (HIV)–Infected and Non–HIV‐Infected Adults
  The Journal of Infectious Diseases, 2000
• Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist™, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions
  Vaccine, 1999
• Prevention and Treatment of Influenza in Immunocompromised Patients
  The American Journal of Medicine, 1997
• Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients
  The Journal of Infectious Diseases, 1997